Opus Genetics, Inc.Opus Genetics, Inc.Opus Genetics, Inc.

Opus Genetics, Inc.

No trades
See on Supercharts

Price target

10.500.000.00%
The 4 analysts offering 1 year price forecasts for IRD have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to IRD in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


IRD EPS for the last quarter is −0.29 USD despite the estimation of −0.24 USD. In the next quarter EPS is expected to reach −0.06 USD. Track more of Opus Genetics, Inc. financials and stay on top of what is up with the company.
In the next quarter Opus Genetics, Inc. revenue is expected to reach ‪8.83 M‬ USD. Check out Opus Genetics, Inc. revenue and earnings and make informed decisions.
According to analysts, IRD price target is 10.50 USD with a max estimate of 15.00 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Opus Genetics, Inc. stock price chart and keep track of the current situation with IRD news and stock market news.